BRPI0412936A - composição para tratamento de vitiligo - Google Patents

composição para tratamento de vitiligo

Info

Publication number
BRPI0412936A
BRPI0412936A BRPI0412936-9A BRPI0412936A BRPI0412936A BR PI0412936 A BRPI0412936 A BR PI0412936A BR PI0412936 A BRPI0412936 A BR PI0412936A BR PI0412936 A BRPI0412936 A BR PI0412936A
Authority
BR
Brazil
Prior art keywords
present
vitiligo
treatment
proline
composition
Prior art date
Application number
BRPI0412936-9A
Other languages
English (en)
Inventor
Carlos Manuel Miyares Cao
Ileana Hollands Barca
Reina Pimienta Lopez
Original Assignee
Ct De Histoterapia Placentaria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Histoterapia Placentaria filed Critical Ct De Histoterapia Placentaria
Publication of BRPI0412936A publication Critical patent/BRPI0412936A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

"COMPOSIçãO PARA TRATAMENTO DE VITILIGO". A presente invenção refere-se ao campo da Dermatologia e, particularmente, a uma composição que pode ser utilizada no campo da cosmética e da medicina, útil para o tratamento de lesões causadas por vitiligo. A composição objeto da presente invenção tem como princípio ativo o aminoácido L-Prolina, que estimula a síntese do pigmento melânico da pele e a reprodução de melanócitos e não apresenta reações secundárias severas, conforme demonstrado nos testes toxicológicos e clínicos realizados. O objetivo técnico da presente invenção é obter um produto de origem sintética, útil no tratamento de vitiligo, que não possui efeitos tóxicos e demonstra ausência de reincidência da enfermidade.
BRPI0412936-9A 2003-08-05 2004-08-03 composição para tratamento de vitiligo BRPI0412936A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20030177 2003-08-05
PCT/CU2004/000008 WO2005011676A1 (es) 2003-08-05 2004-08-03 Composición para el tratamiento del vitíligo

Publications (1)

Publication Number Publication Date
BRPI0412936A true BRPI0412936A (pt) 2006-09-26

Family

ID=34109587

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412936-9A BRPI0412936A (pt) 2003-08-05 2004-08-03 composição para tratamento de vitiligo

Country Status (9)

Country Link
US (1) US20080207733A1 (pt)
EP (1) EP1661565B1 (pt)
CN (1) CN100421660C (pt)
AT (1) ATE376417T1 (pt)
BR (1) BRPI0412936A (pt)
CA (1) CA2534690A1 (pt)
DE (1) DE602004009698D1 (pt)
RU (1) RU2321397C2 (pt)
WO (1) WO2005011676A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA013133B1 (ru) * 2008-12-26 2010-02-26 Некоммерческое Учреждение "Научно-Исследовательский Институт Цитохимии И Молекулярной Фармакологии" Композиция аминокислот подъязычного применения для повышения репигментации кожного покрова при витилиго и способ ее применения
US20160045473A1 (en) * 2012-08-01 2016-02-18 Rory Powell Blake Biological Basis Of Adult Wellness
US20150038547A1 (en) * 2013-07-31 2015-02-05 Rory Powell Blake Biological Basis of Adult Wellness

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2657504B2 (ja) * 1988-01-12 1997-09-24 株式会社資生堂 油中水型乳化組成物
US5484597A (en) * 1993-07-30 1996-01-16 Chesebrough-Pond's Usa Co. Clear hydroalcholic cosmetic microemulsions
CN1106680A (zh) * 1994-02-01 1995-08-16 徐兴沛 强化人体保健液及其生产工艺
US6696417B1 (en) * 1997-11-21 2004-02-24 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin and hair darkening composition
US6323219B1 (en) * 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
CU22695A1 (es) * 1998-07-28 2001-07-31 Ct De Histoterapia Placentaria Formulación para la estimulación de la síntesis del pigmento melánico
US6740326B1 (en) * 1998-09-10 2004-05-25 Bioequal Ag Topical nail care compositions
HUP0201865A2 (en) * 1999-07-02 2002-11-28 Procter & Gamble Compositions comprising organosiloxane resins for delivering oral care substances
US20020197289A1 (en) * 2001-03-23 2002-12-26 L'oreal Compositions and methods for combating the appearance of ageing
EP1342474A1 (en) * 2002-03-08 2003-09-10 Universiteit Leiden The use of proline, poly-proline peptides and proline-rich proteins to quench reactive oxygen species
DE10243233A1 (de) * 2002-09-17 2004-04-15 Phenion Gmbh & Co. Kg Verwendung von Substanzen zum Schutz der Haut

Also Published As

Publication number Publication date
CN100421660C (zh) 2008-10-01
EP1661565B1 (en) 2007-10-24
DE602004009698D1 (de) 2007-12-06
RU2006106708A (ru) 2006-09-10
RU2321397C2 (ru) 2008-04-10
US20080207733A1 (en) 2008-08-28
CN1845732A (zh) 2006-10-11
CA2534690A1 (en) 2005-02-10
WO2005011676A1 (es) 2005-02-10
EP1661565A1 (en) 2006-05-31
ATE376417T1 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
MXPA02012000A (es) Nuevos compuestos de la familia de las n-acilaminoamidas composiciones que los contienen y usos.
DE69932715D1 (de) Pharmazeutische und/oder kosmetische zusammensetzungen enthaltend meerwasser
ATE420621T1 (de) N-acetylhydroxyprolin zur verbesserung der feuchtigkeitsspeicherungsfunktion der epidermis
ATE530226T1 (de) Verwendung von sinapinsäure in nicht- therapeutischen kosmetischen und/oder topischen zubereitungen
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
ATE495728T1 (de) Kosmetische oder dermatologische zubereitungen mit n-acetylcystein
ZA200701798B (en) Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalioproteinases inhibitors
ATE507226T1 (de) 1,3,4-oxadiazol-2-one als ppar-delta-modulatoren und deren verwendung
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
CY1108607T1 (el) Συνθεσεις περιλαμβανουσες ζελατινη-γλυκινη και καροτενοειδη
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
DK1264548T3 (da) Fysiologiske aktive midler indeholdende vicinale-dithioglykoler og anvendelse deraf i forskellige grene af erhvervssektoren
BRPI0412936A (pt) composição para tratamento de vitiligo
MX2009012714A (es) Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
WO2006103119A3 (en) Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
ATE406868T1 (de) Verwendung einer zusammensetzung mit vitamin k1- oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern
KR20160148206A (ko) 피부 질환 개선용 조성물
ATE423564T1 (de) Zusammensetzung für die kosmetische behandlung von altersbedingten dermatologischen symptomen
DE602006019842D1 (de) Verwendung von lecithin als arzneimittel zur behandlung von psoriasis
EP1716859A3 (de) Pflanzenextrakte gegen Halitosis, Gingivitis oder Parodontitis
BR0317925A (pt) Utilização de uma molécula ativa, composição cosmética e processo de tratamento da celulite
JP2021147393A (ja) 酸化ストレス抑制剤
WO2010112713A3 (fr) Peptides eclaircissants activateurs du proteasome et compositions les contenant
WO2010112711A3 (fr) Peptides eclaircissants activateurs du proteasome et compositions les contenant
TH87784B (th) สูตรเฉพาะที่มี o-เดสเมทธิลเวนลาฟาซีน(odv)หรือเกลือของมัน

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.